News

While televisits can address many medical concerns, one frequent reservation expressed by healthcare professionals is that patients during these televisits tend to present too narrow a picture of their clinical condition-resulting in non-comprehensive medical assessments.

Key takeaways from a survey of 250 oncology patients measuring COVID-19’s impact on patient willingness to participate in clinical trials.

The latest industry happenings, all in one place.

Findings from an OCT Clinical survey of researchers from 61 sites in Russia to gain the perspective of an investigator regarding clinical trials during the COVID-19 pandemic.

IMPs for immunotherapeutics require a different mindset, effective strategies, and meticulous planning, among other things, says KCR Trial Execution and Consulting.

Now that the industry has gotten some experience with CDISC standards, teams are aiming to get more from their standardization efforts.

Outlining the five critical hurdles faced by clinical teams conducting studies in these nations amid quarantine and other restrictions.

The four new methodological Patient-Focused Drug Development guidance documents the FDA is currently developing for the industry that incorporate patient experience data into drug development, summarized.

The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology.